Biblio

Export 3145 results:
Author Title Type [ Year(Asc)]
2021
F. Sorrentino, Arighi, A., Serpente, M., Arosio, B., Arcaro, M., Visconte, C., Rotondo, E., Vimercati, R., Ferri, E., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Scarpini, E., Fenoglio, C., and Galimberti, D., “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
M. Van Zeller, Dias, D., Sebastião, A. M., and Valente, C. A., “NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.”, J Alzheimers Dis, vol. 83, no. 3, pp. 939-961, 2021.
H. B. Allen, “A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology.”, J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
S. Nakamura, Yomota, S., Ito, H., Akinaga, N., Hori, A., Chinomi, K., Suzuki, H., Uchida, K., and Asada, T., “A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.
T. Tomoto, Liu, J., Tseng, B. Y., Pasha, E. P., Cardim, D., Tarumi, T., Hynan, L. S., C Cullum, M., and Zhang, R., “One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 2, pp. 841-853, 2021.
J. Perła-Kaján, Włoczkowska, O., Zioła-Frankowska, A., Frankowski, M., A Smith, D., de Jager, C. A., Refsum, H., and Jakubowski, H., “Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1211-1229, 2021.
J. Malone, Jung, J., Tran, L., and Zhao, C., “Periodontal Disease and Risk of Dementia in Medicare Patients with Hepatitis C Virus.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1301-1308, 2021.
M. Ettcheto, Busquets, O., Cano, A., Sánchez-López, E., Manzine, P. R., Espinosa-Jimenez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., Auladell, C., Folch, J., Casadesus, G., and Camins, A., “Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S91-S107, 2021.
J. Krell-Roesch, Syrjanen, J. A., Bezold, J., Trautwein, S., Barisch-Fritz, B., Boes, K., Woll, A., Forzani, E., Kremers, W. K., Machulda, M. M., Mielke, M. M., Knopman, D. S., Petersen, R. C., Vassilaki, M., and Geda, Y. E., “Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
F. Du, Yu, Q., and Yan, S. ShiDu, “PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1749-1761, 2021.
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
E. R. McGrath, Himali, J. J., Levy, D., Yang, Q., DeCarli, C. S., Courchesne, P., Satizabal, C. L., Finney, R., Vasan, R. S., Beiser, A. S., and Seshadri, S., “Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1657-1666, 2021.
A. Pilotto, Imarisio, A., Carrarini, C., Russo, M., Masciocchi, S., Gipponi, S., Cottini, E., Aarsland, D., Zetterberg, H., Ashton, N. J., Hye, A., Bonanni, L., and Padovani, A., “Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 82, no. 3, pp. 913-919, 2021.
M. E. Petersen, Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., H Rosas, D., Zaman, S., Wang, M. - C., Tycko, B., Lee, J., Handen, B., Hartley, S., Fortea, J., and O'Bryant, S., “Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.”, J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
J. Lakey-Beitia, Burillo, A. M., La Penna, G., Hegde, M. L., and Rao, K. S., “Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S335-S357, 2021.
W. Huang, Zeng, F., Gu, Y., Jiang, M., Zhang, X., Yan, X., Kadowaki, T., Mizutani, S., Kashiwazaki, H., Ni, J., and Wu, Z., “Porphyromonas Gingivalis Infection Induces Synaptic Failure via Increased IL-1β Production in Leptomeningeal Cells.”, J Alzheimers Dis, vol. 83, no. 2, pp. 665-681, 2021.
P. L. Nara, Sindelar, D., Penn, M. S., Potempa, J., and W Griffin, S. T., “Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
B. Bahar, Kanagasingam, S., Tambuwala, M. M., Aljabali, A. A. A., Dillon, S. A., Doaei, S., Welbury, R., Chukkapalli, S. S., and Singhrao, S. K., “Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1259-1275, 2021.
M. Hashimoto, Ho, G., Sugama, S., Takenouchi, T., Waragai, M., Sugino, H., Inoue, S., and Masliah, E., “Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.”, J Alzheimers Dis, vol. 81, no. 2, pp. 451-458, 2021.
G. Zhang, Zhang, Y., Shen, Y., Wang, Y., Zhao, M., and Sun, L., “The Potential Role of Ferroptosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 907-925, 2021.
M. Welstead, Luciano, M., Muniz-Terrera, G., Saunders, S., Mullin, D. S., and Russ, T. C., “Predictors of Mild Cognitive Impairment Stability, Progression, or Reversion in the Lothian Birth Cohort 1936.”, J Alzheimers Dis, vol. 80, no. 1, pp. 225-232, 2021.
K. J. Atkins, Scott, D., Silbert, B., Pike, K. E., and Evered, L., “Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.
D. Horstkötter, Deckers, K., and Köhler, S., “Primary Prevention of Dementia: An Ethical Review.”, J Alzheimers Dis, vol. 79, no. 2, pp. 467-476, 2021.
T. J. Krivanek, Gale, S. A., McFeeley, B. M., Nicastri, C. M., and Daffner, K. R., “Promoting Successful Cognitive Aging: A Ten-Year Update.”, J Alzheimers Dis, vol. 81, no. 3, pp. 871-920, 2021.
J. - W. Zhou, Zhao, M., Rang, W. - L., Zhang, X. - Y., Liu, Z. - M., Zhang, L. - R., Wang, T. - X., Wu, C. - T., Cheng, X. - R., and Zhou, W. - X., “Proteome Profiling Identified Amyloid-β Protein Precursor as a Novel Binding Partner and Modulator of VGLUT1.”, J Alzheimers Dis, vol. 81, no. 3, pp. 981-1038, 2021.

Pages